ArticleKidney international reports2026
Prospective Cohort Study of Felzartamab in Rituximab-Resistant Primary Membranous Nephropathy.
Matias Trillini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it